Search - tctmd.com

Displaying 101 - 120 of 250

Sort: Relevancy | Date

Presentation TCT 2018

Is It Time to Move Beyond Angiography for Procedural Planning? DECISION

Presenter: Antonio Colombo, Jeffrey W. Moses, Gregg W. Stone

September 22, 2018

Presentation TCT 2018

Is It Time to Move Beyond Angiography for Procedural Planning? SYNTAX III

Presenter: Antonio Colombo, Jeffrey W. Moses, Antonio L. Bartorelli

September 22, 2018

Presentation TCT 2018

MVD Case Presentation With Heart Team Discussion, Case Introduction

Presenter: Antonio Colombo, Jeffrey W. Moses, Carlos Collet, Pablo Lamelas, John D. Puskas, Alfredo E. Rodriguez, Pieter C. Smits, Wilson Y. Szeto

September 22, 2018

Presentation TCT 2018

Hybrid Revascularization as an Alternative to PCI or CABG

Presenter: Antonio Colombo, Jeffrey W. Moses, John D. Puskas

September 22, 2018

Presentation TCT 2018

PCI for MVD: Is Complete Revascularization the Missing Link? Anatomic or Functional?

Presenter: Antonio Colombo, Jeffrey W. Moses, William F. Fearon

September 22, 2018

Presentation TCT 2018

How Much Has PCI (and CABG) Improved in MVD and LMD: Insights From SYNTAX II and SYNTAX-EXCEL Comparative Analyses

Presenter: Antonio Colombo, Jeffrey W. Moses, Patrick W. Serruys

September 22, 2018

News Opinion Editor's Corner TCT 2018

TCT 2018, Day One: ‘Back to the Future’ With Stents, Stents, and More Stents

Shelley Wood

September 22, 2018

Presentation TCT 2018

Mortality and Stroke Outcomes of PCI vs CABG in MVD and LMD With and Without Diabetes

Presenter: Antonio Colombo, Jeffrey W. Moses, Stuart J. Head

September 22, 2018

Presentation TCT 2018

Defining What Constitutes a Clinically Relevant Peri-Procedural MI: Analysis in > 17,000 Patients

Presenter: Antonio Colombo, Jeffrey W. Moses, Jung-Min Ahn

September 22, 2018

Presentation TCT 2018

TCT-8: Fate Of Deferred Lesions Using State-Of-Art Percutaneous Coronary Revascularization In Patients With De Novo Three Vessel Disease: Lesion Level Analysis At 2 Years Of The SYNTAX II Study

Presenter: Steven R. Bailey, Patrick W. Serruys, Norihiro Kogame

September 22, 2018

Presentation TCT 2018

Optimal Medical Therapy With and Without Coronary Revascularization: Which Drugs Matter? Symptoms, Ischemia, or Prognosis? And Magnitude of Impact

Presenter: David J. Cohen, Sunil V. Rao, David J. Maron

September 22, 2018

News Conference News TCT 2018

EXCEL Deep Dive: Repeat Revascularization, Medical Therapy, and Anemia All Impact Patient Prognosis

Michael O'Riordan

September 21, 2018

Presentation TCT 2018

Three-year Outcomes of Surgical Vs. Endovascular Revascularization for Critical Limb Ischemia: The SPINACH Study

Presenter: Osamu Iida, Shigeru Saito

September 21, 2018

Presentation TCT 2018

TCT-91: Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents versus Thin Durable Polymer Everolimus-Eluting Stents in Patients Undergoing Coronary Revascularization (BIOFLOW V): Acute Coronary Syndrome Subgroup Analysis

Presenter: Alexandre Abizaid, Didier Carrié, Ariel Roguin

September 21, 2018

Presentation TCT 2018

TCT-90: Clinical Outcomes Three Year After Revascularization With a Biodegradable Polymer Ultra-thin Strut Sirolimus-Eluting Stent and a Biodegradable Polymer Biolimus-eluting Stent. From the SORT OUT VII Trial

Presenter: Alexandre Abizaid, Didier Carrié, Julia Ellert

September 21, 2018

Presentation TCT 2018

TCT-108: Long-term Survival After Hybrid Coronary Revascularization for Triple-Vessel Disease: How Does it Compare to Coronary Artery Bypass Surgery or Multi-Vessel Percutaneous Intervention?

Presenter: John D. Puskas, Alfredo Trento, Craig Basman

September 21, 2018

Presentation TCT 2018

TCT-107: Patient-Centered Decision-Making of Revascularization Strategy for Left Main or Multi-Vessel Coronary Artery Disease in Real-World Practice

Presenter: John D. Puskas, Alfredo Trento, Choongki Kim

September 21, 2018

Presentation TCT 2018

TCT-36: The Impact of Guideline-Directed Medical Therapy after Revascularization in Patients With Left Main Coronary Artery Disease: Analysis From the EXCEL Trial

Presenter: Nicholas J. Lembo, Marie-Claude Morice, R. Jay Widmer

September 21, 2018

Presentation TCT 2018

TCT-11: Assessment of the Adenosine-Dependent Hyperemic Response During the Subacute Phase of a Myocardial Infarction: Insights for FFR-Guided Coronary Revascularization in Non-Infarcted-Related Arteries

Presenter: Allen Jeremias, Hernan Mejia-Renteria

September 21, 2018

Presentation TCT 2018

TCT-33: Mortality After Repeat Revascularization Following PCI or CABG for Left Main Coronary Artery Disease: The EXCEL Trial

Presenter: Nicholas J. Lembo, Marie-Claude Morice, Gennaro Giustino

September 21, 2018

Advertisement

Is It Time to Move Beyond Angiography for Procedural Planning? DECISION

Is It Time to Move Beyond Angiography for Procedural Planning? SYNTAX III

MVD Case Presentation With Heart Team Discussion, Case Introduction

Hybrid Revascularization as an Alternative to PCI or CABG

PCI for MVD: Is Complete Revascularization the Missing Link? Anatomic or Functional?

How Much Has PCI (and CABG) Improved in MVD and LMD: Insights From SYNTAX II and SYNTAX-EXCEL Comparative Analyses

TCT 2018, Day One: ‘Back to the Future’ With Stents, Stents, and More Stents

Mortality and Stroke Outcomes of PCI vs CABG in MVD and LMD With and Without Diabetes

Defining What Constitutes a Clinically Relevant Peri-Procedural MI: Analysis in > 17,000 Patients

TCT-8: Fate Of Deferred Lesions Using State-Of-Art Percutaneous Coronary Revascularization In Patients With De Novo Three Vessel Disease: Lesion Level Analysis At 2 Years Of The SYNTAX II Study

Optimal Medical Therapy With and Without Coronary Revascularization: Which Drugs Matter? Symptoms, Ischemia, or Prognosis? And Magnitude of Impact

EXCEL Deep Dive: Repeat Revascularization, Medical Therapy, and Anemia All Impact Patient Prognosis

Three-year Outcomes of Surgical Vs. Endovascular Revascularization for Critical Limb Ischemia: The SPINACH Study

TCT-91: Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents versus Thin Durable Polymer Everolimus-Eluting Stents in Patients Undergoing Coronary Revascularization (BIOFLOW V): Acute Coronary Syndrome Subgroup Analysis

TCT-90: Clinical Outcomes Three Year After Revascularization With a Biodegradable Polymer Ultra-thin Strut Sirolimus-Eluting Stent and a Biodegradable Polymer Biolimus-eluting Stent. From the SORT OUT VII Trial

TCT-108: Long-term Survival After Hybrid Coronary Revascularization for Triple-Vessel Disease: How Does it Compare to Coronary Artery Bypass Surgery or Multi-Vessel Percutaneous Intervention?

TCT-107: Patient-Centered Decision-Making of Revascularization Strategy for Left Main or Multi-Vessel Coronary Artery Disease in Real-World Practice

TCT-36: The Impact of Guideline-Directed Medical Therapy after Revascularization in Patients With Left Main Coronary Artery Disease: Analysis From the EXCEL Trial

TCT-11: Assessment of the Adenosine-Dependent Hyperemic Response During the Subacute Phase of a Myocardial Infarction: Insights for FFR-Guided Coronary Revascularization in Non-Infarcted-Related Arteries

TCT-33: Mortality After Repeat Revascularization Following PCI or CABG for Left Main Coronary Artery Disease: The EXCEL Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content